Paper - WANFANG MED ONLINE

You Position: Home > Paper

Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients

( views:46, downloads:9 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 20

DOI:: 10.3760/cma.j.issn.0366-6999.20141176

Key Word:: hypertension;FK506;nitric oxide synthase

Abstract： Objective Tacrolimus (FK506) is an immunosuppressive drug,which is widely used to prevent rejection of transplanted organs.However,chronic administration of FK506 leads to hypertension in solid organ transplantation patients,and its molecular mechanisms are much more complicated.In this review,we will discuss the above-mentioned molecular mechanisms of FK506-induced hypertension in solid organ transplantation subjects.Data sources The data analyzed in this review were mainly from relevant articles without restriction on the publication date reported in PubMed.The terms "FK506" or "tacrolimus" and "hypertension"were used for the literature search.Study selection Original articles with no limitation of research design and critical reviews containing data relevant to FK506-induced hypertension and its molecular mechanisms were retrieved,reviewed and analyzed.Results There are several molecular mechanisms attributed to FK506-induced hypertension in solid organ transplantation subjects.First,FK506 binds FK506 binding protein 12 and its related isoform 12.6 (FKBP12/12.6) and removes them from intracellular ryanodine receptors that induce a calcium ion leakage from the endoplasmic/sarcoplasmic reticulum.The conventional protein kinase C beta II (cPKCβⅡ)-mediated phosphorylation of endothelial nitric oxide (NO) synthase at Thr495,which reduces the production of NO,was activated by calcium ion leakage.Second,transforming growth factor receptor/SMAD2/3 signaling activation plays an important role in Treg/Th17 cell imbalance in T cells which toget converge to cause inflammation,endothelial dysfunction,and hypertension following tacrolimus treatment.Third,the activation of with-no-K(Lys) kinases/STE20/SPS1-related proline/alanine-rich kinase/thiazide-sensitive sodium chloride co-transporter (WNKs/SPAK/NCC) pathway has a central role in tacrolimus-induced hypertension.Finally,the enhanced activity of renal renin-angiotensin-aldosterone system seems to play a crucial role in the pathophysiology of FK506-induced hypertension.Conclusion FK506 plays a predominant role in the pathophysiology of hypertension in solid organ transplantation subjects.

Reference

[1]Xue Wenrui,ZHANG Qiang,XU Yue,etc.Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis[J].2014,(12).
[2]Lopez Hoyos M,Rodrigo E,Palomar R,etc.Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.[J].2006,82(4).
[3]Wen, H.,Song, Y.,Yang, H.-J.,etc.Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels[J].2012,517(1).
[4]Yun-Min Zheng,Yong-Xiao Wang,Sidney Fleischer,etc.FKBP12.6 and cADPR regulation of Ca~(2+)release in smooth muscle cells[J].2004,286(3 Pt.1).
[5]Anne-Marie B. Brillantes,Karol Ondrias,Andrew Scott,etc.Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein[J].1994,77(4).
[6]Benkirane,Viel EC,Lemarie CA.Immune regulation and vascular inflammation in genetic hypertension.[J].2010,298(3 Pt.2).
[7]Ruiz JC,Arias M,Fernandez Fresnedo G,etc.Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients.[J].2010,24(3).
[8]Mangan PR,Harrington LE,Murphy TL,etc.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.[J].2005,6(11).
[9]Hu DC,Hong A,Burtner C,etc.Correction of renal hypertension after kidney transplantation from a donor with Gitelman syndrome.[J].2006,331(2).
[10]Hoorn, E. J.,Ellison, D. H..WNK kinases and the kidney[J].2012,318(9).
[11]L M, Keranen,E M, Dutil,A C, Newton.Protein kinase C is regulated in vivo by three functionally distinct phosphorylations.[J].1995,5(12).
[12]Lenka, Ho?ková,Ivan, Málek,Josef, Kautzner,etc.Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system.[J].2014,37.
[13]Howie AJ,Furstenberg A,Bachmann S,etc.The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.[J].2011,17(10).
[14]Fatema H. Rafiqi,Annie Mercier Zuber,Mark Glover,etc.Role of the WNK-activated SPAK kinase in regulating blood pressure[J].2010,2(2).
[15]Gerardo Gamba.Regulation of the renal Na~+-Cl cotransporter by phosphorylation and ubiquitylation[J].2012,303(6 Pt.2).
[16]Lanner,J.T..Ryanodine receptor physiology and its role in disease[J].2012,740.
[17]Mangray M,Vella JP.Hypertension after kidney transplant.[J].2011,57(2).
[18]Liu F.,Chen YG.,Massague J..Mechanism of Tgf-Beta Receptor Inhibition by Fkbp12[J].1997,16(13).
[19]Salzberg DJ,Weir MR.Management of hypertension in the transplant patient.[J].2011,5(5).
[20]Pieper GM,Khanna AK.NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model.[J].2007,22(2).
[21]Tongwen Wang,Patricia K. Donahoe.THE IMMUNOPHILIN FKBP12: A MOLECULAR GUARDIAN OF THE TGF-beta FAMILY TYPE I RECEPTORS[J].2004,9(1).
[22]Gerardo, Gamba.The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional properties, and regulation by WNKs.[J].2009,297(4).
[23]Currie S,Macmillan D,McCarron JG.FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca(2+) release in colonic but not aortic smooth muscle.[J].2008,43(6).
[24]Ponticelli C,Cucchiari D,Graziani G.Hypertension in kidney transplant recipients.[J].2011,24(6).
[25]S O, Marx,K, Ondrias,A R, Marks.Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors)[J].1998,281(5378).
[26]Cornea RL,Nitu FR,Fruen BR,etc.Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer.[J].2010,285(25).
[27]T, Wang,B Y, Li,P D, Danielson,etc.The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.[J].1996,86.
[28]Chiasson,V.L.,Jones,K.A.,Kopriva,S.E.,etc.Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis[J].2012,82(8).
[29]Edyta, Zbroch,Jolanta, Ma?yszko,Micha?, My?liwiec,etc.Hypertension in solid organ transplant recipients.[J].1900,17.
[30]Neves MF,Kasal DA,Schiffrin EL,etc.T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.[J].2011,57(3).
[31]A.P. Timerman,T. Jayaraman,G. Wiederrecht,etc.The Ryanodine Receptor from Canine Heart Sarcoplasmic Reticulum Is Associated with a Novel FK-506 Binding Protein[J].1994,198(2).
[32]Benjamin Ko,Abinash C. Mistry,Lauren Hanson,etc.Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway[J].2013,305(3 Pt.2).
[33]MacMillan,D..FK506 binding proteins: Cellular regulators of intracellular Ca 2+ signalling[J].2013,700(1).
[34]Girgenrath,T.,Mahalingam,M.,Svensson,B.,etc.N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins[J].2013,288(22).
[35]Heinrich E. Lob,Louise A. McCann,Meena S. Madhur.Interleukin 17 Promotes Angiotensin II-Induced Hypertension and Vascular Dysfunction[J].2010,55(2 Pt.2).
[36]Mitchell,B.M.,Chatterjee,P.,Nguyen,H.,etc.Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension[J].2013,97(4).
[37]Long C,Mitchell BM,Chiasson VL,etc.Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect.[J].2009,75(7).
[38]Cook LG,Hamilton SL,Mitchell BM,etc.FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure.[J].2007,49(3).
[39]Furukawa K,Inaba S,Miyamori I,etc.Mechanisms of FK 506-induced hypertension in the rat.[J].1999,33(1).
[40].The sodium chloride cotransporter SLC12A3: New roles in sodium, potassium, and blood pressure regulation[J].2014,466(1).
[41]Takimoto T,Wakabayashi Y,Sekiya T,etc.Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.[J].2010,185(2).
[42]Wadei HM,Textor SC.Hypertension in the kidney transplant recipient.[J].2010,24(3).
[43]Qin H,Wang L,Feng T.TGF-beta promotes Th17 cell development through inhibition of SOCS3.[J].2009,183(1).
[44]O'Shaughnessy,K.M.,Glover,M..Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia[J].2013,40(12).
[45]Mohrbach J,Presser D,Sester U.Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens.[J].2009,76(5).
[46]Nelson JH,Ellison DH,McCormick JA,etc.The WNK kinase network regulating sodium, potassium, and blood pressure.[J].2011,22(4).
[47]F H, Wilson,S, Disse-Nicodème,K A, Choate,etc.Human hypertension caused by mutations in WNK kinases.[J].2001,293(5532).
[48]Sakellaraki P,Mouzaki A,Georgakopoulos T,etc.Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.[J].2010,32(1).
[49]G P, Ahern,P R, Junankar,A F, Dulhunty.Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.[J].1994,352(3).
[50]Pushpinder Dhillion,1 Kedra Wallace,1 Florian Herse,etc.IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy[J].2012,303(2 Pt.2).
[51]Paul J,Romero R,Campistol JM,etc.Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade.[J].2004,19(Suppl.3).
[52]Stokes J B.Sodium chloride absorption by the urinary bladder of the winter flounder. A thiazide-sensitive, electrically neutral transport system.[J].1984.
[53]Malhotra N,Robertson E,Kang J.SMAD2 is essential for TGF beta-mediated Th17 cell generation.[J].2010,285(38).
[54]Jones JL,Reynolds DF,Lai FA,etc.Ryanodine receptor binding to FKBP12 is modulated by channel activation state.[J].2005,118(Pt.20).
[55]MacMillan D,McCarron JG.Regulation by FK506 and rapamycin of Ca2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR.[J].2009,158(4).
[56]Fleming I.Molecular mechanisms underlying the activation of eNOS.[J].2010,459(6).
[57]T, Jayaraman,A M, Brillantes,A P, Timerman,etc.FK506 binding protein associated with the calcium release channel (ryanodine receptor).[J].1992,267.